BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24145140)

  • 21. The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia.
    Aberuyi N; Rahgozar S; Khosravi Dehaghi Z; Moafi A; Masotti A; Paolini A
    Onco Targets Ther; 2017; 10():3373-3380. PubMed ID: 28744141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer.
    Mittal K; Donthamsetty S; Kaur R; Yang C; Gupta MV; Reid MD; Choi DH; Rida PCG; Aneja R
    Br J Cancer; 2017 Apr; 116(9):1186-1194. PubMed ID: 28334734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics.
    Lin G; Mi P; Chu C; Zhang J; Liu G
    Adv Sci (Weinh); 2016 Nov; 3(11):1600134. PubMed ID: 27980988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells.
    Ma Y; Miao Y; Peng Z; Sandgren J; De Ståhl TD; Huss M; Lennartsson L; Liu Y; Nistér M; Nilsson S; Li C
    Springerplus; 2016; 5(1):1861. PubMed ID: 27822437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia.
    Yadav BD; Samuels AL; Wells JE; Sutton R; Venn NC; Bendak K; Anderson D; Marshall GM; Cole CH; Beesley AH; Kees UR; Lock RB
    Oncotarget; 2016 Sep; 7(37):58728-42. PubMed ID: 27623214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of lncRNA NEAT1 mitigates multidrug resistance by inhibiting ABCG2 in leukemia.
    Gao C; Zhang J; Wang Q; Ren C
    Oncol Lett; 2016 Aug; 12(2):1051-1057. PubMed ID: 27446393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis pathway signature for prediction of treatment response and clinical outcome in childhood high risk B-Precursor acute lymphoblastic leukemia.
    Chang YH; Yang YL; Chen CM; Chen HY
    Am J Cancer Res; 2015; 5(5):1844-53. PubMed ID: 26175952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mRNA overexpression of
    Azizi Z; Rahgozar S; Moafi A; Dabaghi M; Nadimi M
    Biomed Rep; 2015 May; 3(3):371-374. PubMed ID: 26137238
    [No Abstract]   [Full Text] [Related]  

  • 29. Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells.
    Kang Q; Yan S
    Exp Ther Med; 2015 Apr; 9(4):1345-1350. PubMed ID: 25780433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of ATP-binding cassette transporter A2 in childhood acute lymphoblastic leukemia multidrug resistance.
    Aberuyi N; Rahgozar S; Moafi A
    Iran J Ped Hematol Oncol; 2014; 4(3):118-26. PubMed ID: 25254091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia.
    Lu Y; Kham SK; Ariffin H; Oei AM; Lin HP; Tan AM; Quah TC; Yeoh AE
    Br J Cancer; 2014 Mar; 110(6):1673-80. PubMed ID: 24434428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death.
    Cortez MA; Scrideli CA; Yunes JA; Valera ET; Toledo SR; Pavoni-Ferreira PC; Lee ML; Petrilli AS; Brandalise SR; Tone LG
    Pediatr Blood Cancer; 2009 Dec; 53(6):996-1004. PubMed ID: 19672972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
    Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
    Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia.
    Swerts K; De Moerloose B; Dhooge C; Laureys G; Benoit Y; Philippé J
    Eur J Cancer; 2006 Feb; 42(3):295-309. PubMed ID: 16324833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.
    Rahgozar S; Moafi A; Abedi M; Entezar-E-Ghaem M; Moshtaghian J; Ghaedi K; Esmaeili A; Montazeri F
    Cancer Biol Ther; 2014 Jan; 15(1):35-41. PubMed ID: 24145140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia.
    Efferth T; Gillet JP; Sauerbrey A; Zintl F; Bertholet V; de Longueville F; Remacle J; Steinbach D
    Mol Cancer Ther; 2006 Aug; 5(8):1986-94. PubMed ID: 16928819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
    Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.